BFO
Boston Family Office Portfolio holdings
AUM
$1.51B
This Quarter Return
+15.63%
1 Year Return
+12.61%
3 Year Return
+54.38%
5 Year Return
+90.66%
10 Year Return
+237.26%
AUM
$925M
AUM Growth
+$925M
(+15%)
Cap. Flow
-$635K
Cap. Flow
% of AUM
-0.07%
Top 10 Holdings %
Top 10 Hldgs %
22.31%
Holding
255
New
7
Increased
77
Reduced
98
Closed
5
Top Buys
| 1 |
Air Products & Chemicals
APD
|
$7.1M |
| 2 |
SPDR S&P Biotech ETF
XBI
|
$2.9M |
| 3 |
Microsoft
MSFT
|
$2.31M |
| 4 |
CVS Health
CVS
|
$2.12M |
| 5 |
Visa
V
|
$1.74M |
Top Sells
| 1 |
Linde
LIN
|
$7.75M |
| 2 |
CELG
Celgene Corp
CELG
|
$5.83M |
| 3 |
Air Lease Corp
AL
|
$2.7M |
| 4 |
American Tower
AMT
|
$2.17M |
| 5 |
Kinder Morgan
KMI
|
$1.46M |
Sector Composition
| 1 | Healthcare | 16.89% |
| 2 | Technology | 16.36% |
| 3 | Industrials | 11.15% |
| 4 | Consumer Staples | 8.91% |
| 5 | Financials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Roper Technologies
ROP
$56.6B
| $10.7M | 1.16% | 31,272 -234 | -0.7% | -$80K |
|
27
Exxon Mobil
XOM
$487B
| $10.7M | 1.15% | 132,158 -5,057 | -4% | -$409K |
|
28
Stryker
SYK
$150B
| $10.5M | 1.14% | 53,287 +1,118 | +2% | +$221K |
|
29
Alphabet (Google) Class C
GOOG
$2.58T
| $10.5M | 1.13% | 8,938 +457 | +5% | +$536K |
|
|
30
Air Products & Chemicals
APD
$65.5B
| $10.4M | 1.12% | 54,420 +37,193 | +216% | +$7.1M |
|
31
Dollar Tree
DLTR
$22.8B
| $10.1M | 1.09% | 96,132 -1,475 | -2% | -$155K |
|
32
Verizon
VZ
$186B
| $10.1M | 1.09% | 170,128 +281 | +0.2% | +$16.6K |
|
33
Thermo Fisher Scientific
TMO
$186B
| $10M | 1.08% | 36,618 +5,029 | +16% | +$1.38M |
|
34
General Mills
GIS
$26.4B
| $9.89M | 1.07% | 191,125 -2,350 | -1% | -$122K |
|
|
RTN
35
DELISTED
Raytheon Company
RTN
| $9.56M | 1.03% | 52,477 +4,707 | +10% | +$857K |
|
36
NextEra Energy, Inc.
NEE
$148B
| $8.91M | 0.96% | 46,076 +361 | +0.8% | +$69.8K |
|
37
PepsiCo
PEP
$204B
| $8.9M | 0.96% | 72,590 -3,145 | -4% | -$385K |
|
38
Aflac
AFL
$57.2B
| $8.63M | 0.93% | 172,645 -1,144 | -0.7% | -$57.2K |
|
39
Abbott
ABT
$231B
| $8.48M | 0.92% | 106,027 -1,012 | -0.9% | -$80.9K |
|
40
TE Connectivity
TEL
$61B
| $8.25M | 0.89% | 102,151 -598 | -0.6% | -$48.3K |
|
41
Merck
MRK
$210B
| $8.07M | 0.87% | 96,976 -5,065 | -5% | -$421K |
|
42
Invesco QQQ Trust
QQQ
$364B
| $7.5M | 0.81% | 41,759 +82 | +0.2% | +$14.7K |
|
43
Danaher
DHR
$147B
| $7.15M | 0.77% | 54,125 -1,290 | -2% | -$170K |
|
|
44
CVS Health
CVS
$92.8B
| $7.1M | 0.77% | 131,685 +39,358 | +43% | +$2.12M |
|
45
McDonald's
MCD
$224B
| $7.09M | 0.77% | 37,321 -967 | -3% | -$184K |
|
46
3M
MMM
$82.8B
| $6.99M | 0.76% | 33,654 -82 | -0.2% | -$17K |
|
47
Gilead Sciences
GILD
$140B
| $6.94M | 0.75% | 106,713 -2,091 | -2% | -$136K |
|
48
AbbVie
ABBV
$372B
| $6.04M | 0.65% | 74,963 -1,366 | -2% | -$110K |
|
49
S&P Global
SPGI
$167B
| $5.96M | 0.64% | 28,310 -270 | -0.9% | -$56.9K |
|
50
Idexx Laboratories
IDXX
$51.8B
| $5.92M | 0.64% | 26,492 +1,373 | +5% | +$307K |
|